Evaluation of an immunotherapeutic DNA-vaccine in biochemically relapsed prostate cancer

Neal D. Shore; Elisabeth I. Heath; Luke T. Nordquist; Heather H. Cheng; Kamalnayan Bhatt; Matthew Morrow; Trevor McMullan; Kimberly Kraynyak; Jessica Lee; Brian Sacchetta; et al.

doi:10.1200/JCO.2018.36.15_suppl.5078

Back

Evaluation of an immunotherapeutic DNA-vaccine in biochemically relapsed prostate cancer

Journal article

Peer reviewed

Evaluation of an immunotherapeutic DNA-vaccine in biochemically relapsed prostate cancer

Neal D. Shore, Elisabeth I. Heath, Luke T. Nordquist, Heather H. Cheng, Kamalnayan Bhatt, Matthew Morrow, Trevor McMullan, Kimberly Kraynyak, Jessica Lee, Brian Sacchetta, …

Journal of clinical oncology, Vol.36(15_suppl), pp.5078-5078

05/20/2018

DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.5078

Metrics

1 Record Views

Details

Title: Evaluation of an immunotherapeutic DNA-vaccine in biochemically relapsed prostate cancer
Creators: Neal D. Shore - Carolina Urologic Research Center
Elisabeth I. Heath - Wayne State University
Luke T. Nordquist - Urology Cancer Center and GU Research Network
Heather H. Cheng - University of Washington
Kamalnayan Bhatt - Inovio Pharmaceuticals (United States)
Matthew Morrow - Inovio Pharmaceuticals (United States)
Trevor McMullan - Inovio Pharmaceuticals (United States)
Kimberly Kraynyak - Inovio Pharmaceuticals (United States)
Jessica Lee - Inovio Pharmaceuticals (United States)
Brian Sacchetta - Inovio Pharmaceuticals (United States)
et al.
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.5078-5078
Identifiers: 991006262305302656
Academic Unit: Radiology
Language: English
Resource Type: Journal article

Evaluation of an immunotherapeutic DNA-vaccine in biochemically relapsed prostate cancer

Related links

Metrics

Details